Idorsia-CFO: Mittelbeschaffung ist herausfordernd

(3:21)

Idorsia: Listing success story on SIX Swiss Exchange

(4:1econd)

Idorsia-CEO: Wollen vor Rücktritt die Zukunft des Unternehmens sichern

(1:12)

Idorsia-CEO: Wir müssen den Markt nicht unbedingt anzapfen

(2:11)

NEXT Pharma Stuff - Speaking with Michelle Bridenbaker from Idorsia

(11:40)

Idorsia holiday party 2018

(2:9)

How to Sell to CFOs In 2023 (Crash Course)

(6:50)

Cramer: This biotech stock could be worth over $100 billion on an FDA approval

(5:19)

Biotech visionary Jean-Paul Clozel: \

(24:32)

Understanding the Modern CFO: Rethinking The Role

(18:8)

4 Word-for-Word Sales Questions to Build Buying URGENCY

(22:1econd)

CFO Speak: Qualities of a modern day CFO

(6:33)

Idorsia - Reaching Out for More (French Subtitled)

(2:38)

SEF.Talks: Ehepaar Clozel

(7:59)

2019 Idorsia Year End Event - Gingerbread Forest

(1:55)

What Is A Medical Science Liaison?

(8:)

Workday Interview with Alight Solutions' CFO

(17:28)

Success stories from issuers on SIX Swiss Exchange

(3:44)

Exclusive interview with Lombard International Group CFO

(7:53)

Idorsia - 2025 profitabel?

(10:56)

The Evolution of CFOs: From Enablers to Business Partners

(49)

Introduction to iFD: Fractional CFOs

(59)

IP \u0026 SMEs: Taking your ideas to market

(1:56)

NOW CFO | Specialized Roles

(1:35)

CFO Patronis Spicer \u0026 Co Interview

(6:20)

The evolving role of CFOs

(6:53)

What is a Personal CFO?

(1:14)

Reconciling IFRS Financial Reporting with Regulatory Filings - A former CFO's Experience

(53:31)

Lonza: Equity and debt capital funding success story on SIX Swiss Exchange

(2:54)

Galenica: IPO and debt capital funding success story on SIX Swiss Exchange

(3:38)